Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic Diversity and Population Structure of Mycobacterium bovis at the Human-Animal-Ecosystem Interface in France: "A One Health Approach".
Appegren A, Boschiroli ML, De Cruz K, Michelet L, Héry-Arnaud G, Kempf M, Lanotte P, Bemer P, Peuchant O, Pestel-Caron M, Skalli S, Brasme L, Martin C, Enault C, Carricajo A, Guet-Revillet H, Ponsoda M, Jacomo V, Bourgoin A, Trombert-Paolantoni S, Carrière C, Dupont C, Conquet G, Galal L, Banuls AL, Godreuil S. Appegren A, et al. Among authors: guet revillet h. Pathogens. 2023 Apr 1;12(4):548. doi: 10.3390/pathogens12040548. Pathogens. 2023. PMID: 37111434 Free PMC article.
Low performance of interferon gamma release assay Quantiferon-TB gold coupled or not with Pst1/3/lipoglycan humoral detection to predict Mycobacterium tuberculosis complex disease in a low-burden area.
Martinez-Rivera S, Guet-Revillet H, Herin F, Martin-Blondel G, Miedouge M, Billon L, Treiner E, Renaudineau Y. Martinez-Rivera S, et al. Among authors: guet revillet h. Tuberculosis (Edinb). 2023 Dec;143:102416. doi: 10.1016/j.tube.2023.102416. Epub 2023 Oct 5. Tuberculosis (Edinb). 2023. PMID: 37844483
EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption.
Pinilla M, Mazars R, Vergé R, Gorse L, Paradis M, Suire B, Santoni K, Robinson KS, Toh GA, Prouvensier L, Leon-Icaza SA, Hessel A, Péricat D, Murris M, Guet-Revillet H, Henras A, Buyck J, Ravet E, Zhong FL, Cougoule C, Planès R, Meunier E. Pinilla M, et al. Among authors: guet revillet h. J Exp Med. 2023 Oct 2;220(10):e20230104. doi: 10.1084/jem.20230104. Epub 2023 Aug 29. J Exp Med. 2023. PMID: 37642996 Free PMC article.
High Prevalence of OXA-23 Carbapenemase-Producing Proteus mirabilis among Amoxicillin-Clavulanate-Resistant Isolates in France.
Lombes A, Bonnin RA, Laurent F, Guet-Revillet H, Bille E, Cattoir V, Fangous MS, Le Brun C, Fihman V, Janvier F, Otto MP, Potron A, Corvec S, Ruffier d'Epenoux L, Mizrahi A, Dortet L; GMC Study Group. Lombes A, et al. Among authors: guet revillet h. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0198321. doi: 10.1128/AAC.01983-21. Epub 2021 Dec 20. Antimicrob Agents Chemother. 2022. PMID: 34930033 Free PMC article.
Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study.
Bemer P, Peuchant O, Guet-Revillet H, Bador J, Balavoine C, Basille D, Beltramo G, Blanc FX, Blanchard E, Boulanger S, Bourgoin A, Boutoille D, Cambau E, Canis F, Caparros D, Carricajo A, Carrière C, Couetdic G, Couturaud F, Dalphin JC, Degot T, Desquiens M, Devouassoux G, Duez JM, Dumitrescu O, Dupuy-Grasset M, Gaudart A, Georges M, Godet C, Godreuil S, Guillouzouic A, Hamdad-Daoudi F, Héry-Arnaud G, Koebel C, Lagrange A, Lanotte P, Marchand-Adam S, Mougari F, Murris M, Patry I, Pérouse de Montclos M, Raskine L, Risso K, Segonds C, Sicard D, Terru D, Vachée A, Vergnon JM, Martin C, Schramm F, Andrejak C. Bemer P, et al. Among authors: guet revillet h. BMC Pulm Med. 2021 Oct 26;21(1):333. doi: 10.1186/s12890-021-01701-5. BMC Pulm Med. 2021. PMID: 34702233 Free PMC article.
In Vitro Antimicrobial Susceptibility Profiles of Gram-Positive Anaerobic Cocci Responsible for Human Invasive Infections.
Guérin F, Dejoies L, Degand N, Guet-Revillet H, Janvier F, Corvec S, Barraud O, Guillard T, Walewski V, Gallois E, Cattoir V, On Behalf Of The Gmc Study Group. Guérin F, et al. Among authors: guet revillet h. Microorganisms. 2021 Aug 4;9(8):1665. doi: 10.3390/microorganisms9081665. Microorganisms. 2021. PMID: 34442745 Free PMC article.
Mycobacterium chimaera Genomics With Regard to Epidemiological and Clinical Investigations Conducted for an Open Chest Postsurgical Mycobacterium chimaera Infection Outbreak.
Lecorche E, Daniau C, La K, Mougari F, Benmansour H, Kumanski S, Robert J, Fournier S, Lebreton G, Carbonne A, Cambau E; CNR-MyRMA. Lecorche E, et al. Open Forum Infect Dis. 2021 Apr 16;8(6):ofab192. doi: 10.1093/ofid/ofab192. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34189167 Free PMC article.
Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study.
Rousset S, Lafaurie M, Guet-Revillet H, Protin C, Le Grusse J, Derumeaux H, Gandia P, Nourhashemi F, Sailler L, Sommet A, Delobel P, Martin-Blondel G. Rousset S, et al. Among authors: guet revillet h. Drugs Aging. 2021 Jan;38(1):43-52. doi: 10.1007/s40266-020-00811-9. Epub 2020 Nov 4. Drugs Aging. 2021. PMID: 33145702
40 results